Details for New Drug Application (NDA): 040164
✉ Email this page to a colleague
NDA 040164 describes AKPENTOLATE, which is a drug marketed by Rising and is included in two NDAs. Additional details are available on the AKPENTOLATE profile page.
The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Summary for 040164
| Tradename: | AKPENTOLATE |
| Applicant: | Rising |
| Ingredient: | cyclopentolate hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040164
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Jan 13, 1997 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
